These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 25526480)

  • 41. Incidence of de novo malignancy and all-cause mortality among heart transplant recipients.
    Barrera FJ; Mostofsky E; Salia S; Lehman L; Liou L; Mucci L; Mittleman MA
    Int J Cardiol; 2024 Nov; 415():132455. PubMed ID: 39153512
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Post-transplant malignancy: a burdensome complication in renal allograft recipients in Korea.
    Kim JH; Kim SO; Han DJ; Park SK
    Clin Transplant; 2014 Apr; 28(4):434-42. PubMed ID: 24750289
    [TBL] [Abstract][Full Text] [Related]  

  • 43. De novo malignancy in organ transplant recipients in Taiwan: a nationwide cohort population study.
    Tsai HI; Lee CW; Kuo CF; See LC; Liu FC; Chiou MJ; Yu HP
    Oncotarget; 2017 May; 8(22):36685-36695. PubMed ID: 27821818
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The 28-year incidence of de novo malignancies after liver transplantation: A single-center analysis of risk factors and mortality in 1616 patients.
    Rademacher S; Seehofer D; Eurich D; Schoening W; Neuhaus R; Oellinger R; Denecke T; Pascher A; Schott E; Sinn M; Neuhaus P; Pratschke J
    Liver Transpl; 2017 Nov; 23(11):1404-1414. PubMed ID: 28590598
    [TBL] [Abstract][Full Text] [Related]  

  • 45. De Novo Urological Malignancies After Renal Transplantation: An Asian 30-Year Experience.
    Lee HJ; Lim EJ; Woo SJQ; Aslim EJ; Ng LG; Gan VHL
    Clin Transplant; 2024 Jul; 38(7):e15415. PubMed ID: 39049619
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-term probability of and mortality from de novo malignancy after liver transplantation.
    Watt KD; Pedersen RA; Kremers WK; Heimbach JK; Sanchez W; Gores GJ
    Gastroenterology; 2009 Dec; 137(6):2010-7. PubMed ID: 19766646
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Low Incidence of Malignancy After Heart Transplantation in Taiwan.
    Wang YJ; Chi NH; Chou NK; Huang SC; Wang CH; Wu IH; Yu HY; Chen YS; Tsao CI; Shun CT; Tsai JT; Wang SS
    Transplant Proc; 2016 Apr; 48(3):974-7. PubMed ID: 27234782
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Assessment of Anastomotic Biliary Complications in Adult Patients Undergoing High-Acuity Liver Transplant.
    Kaldas FM; Korayem IM; Russell TA; Agopian VG; Aziz A; DiNorcia J; Farmer DG; Yersiz H; Hiatt JR; Busuttil RW
    JAMA Surg; 2019 May; 154(5):431-439. PubMed ID: 30758485
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Malignancies after renal transplantation in Taiwan: a nationwide population-based study.
    Li WH; Chen YJ; Tseng WC; Lin MW; Chen TJ; Chu SY; Hwang CY; Chen CC; Lee DD; Chang YT; Wang WJ; Liu HN
    Nephrol Dial Transplant; 2012 Feb; 27(2):833-9. PubMed ID: 21633099
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Incidence and survival rate of de novo tumors in liver transplants.
    Bernal Bellido C; Suárez Artacho G; Álamo Martínez JM; Marin Gómez LM; Cepeda Franco C; Barrera Pulido L; Praena Fernández JM; Padillo Ruiz J; Gómez Bravo MÁ
    Cir Esp (Engl Ed); 2018 Oct; 96(8):501-507. PubMed ID: 30017062
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increased incidence of early de novo cancer in liver graft recipients treated with cyclosporine: an association with C2 monitoring and recipient age.
    Tjon AS; Sint Nicolaas J; Kwekkeboom J; de Man RA; Kazemier G; Tilanus HW; Hansen BE; van der Laan LJ; Tha-In T; Metselaar HJ
    Liver Transpl; 2010 Jul; 16(7):837-46. PubMed ID: 20583092
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparative Review of Standardized Incidence Ratio of Nonlymphoid, De Novo Malignancies After Liver Transplant Versus After Kidney Transplant.
    Kim A; Waldron O; Daoud D; Huang Y; Patel J; Hong J; Butler T; Jain A
    Exp Clin Transplant; 2024 Aug; 22(8):600-606. PubMed ID: 39254071
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Malignancy following renal transplantation.
    Yang TC; Shu KH; Cheng CH; Wu MJ; Lian JD
    Zhonghua Yi Xue Za Zhi (Taipei); 1998 May; 61(5):281-8. PubMed ID: 9650432
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparative incidence of de novo nonlymphoid malignancies after liver transplantation under tacrolimus using surveillance epidemiologic end result data.
    Jain AB; Yee LD; Nalesnik MA; Youk A; Marsh G; Reyes J; Zak M; Rakela J; Irish W; Fung JJ
    Transplantation; 1998 Nov; 66(9):1193-200. PubMed ID: 9825817
    [TBL] [Abstract][Full Text] [Related]  

  • 55. De novo malignancies after liver transplantation: a major cause of late death.
    Fung JJ; Jain A; Kwak EJ; Kusne S; Dvorchik I; Eghtesad B
    Liver Transpl; 2001 Nov; 7(11 Suppl 1):S109-18. PubMed ID: 11689783
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immunosuppressive regimen and risk for de novo malignancies after liver transplantation for alcoholic liver disease.
    Dumortier J; Maucort-Boulch D; Poinsot D; Thimonier E; Chambon-Augoyard C; Ducroux E; Vallin M; Walter T; Robinson P; Guillaud O; Boillot O
    Clin Res Hepatol Gastroenterol; 2018 Oct; 42(5):427-435. PubMed ID: 29861393
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Spectrum of De Novo Cancers and Predictors in Liver Transplantation: Analysis of the Scientific Registry of Transplant Recipients Database.
    Zhou J; Hu Z; Zhang Q; Li Z; Xiang J; Yan S; Wu J; Zhang M; Zheng S
    PLoS One; 2016; 11(5):e0155179. PubMed ID: 27171501
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Survival Benefit of Early Cancer Detection Through Regular Endoscopic Screening for De Novo Gastric and Colorectal Cancers in Korean Liver Transplant Recipients.
    Jung DH; Hwang S; Song GW; Ahn CS; Moon DB; Ha TY; Kim KH; Park GC; Kim BS; Park IJ; Lim SB; Kim JC; Yoo MW; Byeon JS; Jung HY; Lee GH; Myung SJ; Choe J; Choi JY; Park HW; Lee SG
    Transplant Proc; 2016; 48(1):145-51. PubMed ID: 26915860
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunosuppression, Race, and Donor-Related Risk Factors Affect De novo Cancer Incidence Across Solid Organ Transplant Recipients.
    Bhat M; Mara K; Dierkhising R; Watt KDS
    Mayo Clin Proc; 2018 Sep; 93(9):1236-1246. PubMed ID: 30064826
    [TBL] [Abstract][Full Text] [Related]  

  • 60. De novo malignancies following liver transplantation: a case-control study with long-term follow-up.
    Yao FY; Gautam M; Palese C; Rebres R; Terrault N; Roberts JP; Peters MG
    Clin Transplant; 2006; 20(5):617-23. PubMed ID: 16968488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.